NASDAQ · Biotechnology
Gilead Sciences, Inc. (GILD)
Gilead develops antiviral, oncology and inflammatory-disease medicines and has a large HIV treatment franchise. Founded in 1987 and headquartered in Foster City, California, Gilead Sciences, Inc. employs approximately 18,000 people.
Quote currency: USD. Market data may be delayed and may differ from current market levels.
Price$146.30
Change+0.49%
Market cap181.41bn
P/E ration/a
Analyst consensusBuy
Price target$157.41
Next earningsUnavailable
Dividend yield2.25%
Company profile
Headquarters
Foster City, California
Founded
1987
Employees
18,000
Related coverage
No explicitly linked editorial coverage is currently associated with this company page.